UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma

NCT00734877 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

382

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: M-VTD-PACE
DRUG: TT3-LITE Regimen (L-TT3)

Sponsor

University of Arkansas

Collaborators

[object Object]